Anzeige
Meldung des Tages: China kartiert den Meeresboden. Das Pentagon fordert Nickel. Ein Unternehmen mit 27 Mio. CAD Bewertung hat soeben reagiert.

INNOCAP INC News

Aktie
WKN:  ISIN:  US45773A1079 US-Symbol:  INNO
Keine aktuellen Kursdaten verfügbar
Depot/Watchlist
Dieses Wertpapier ist nicht mehr handelbar.
Marktkapitalisierung *
-
Streubesitz
-
KGV
-
Index-Zuordnung
-

INNOCAP INC News

06.04.26 - PR Newswire
Innocan Pharma Announces Closing of Additional Debenture
Innocan Pharma Announces Closing of Additional Debenture PR Newswire
31.03.26 - PR Newswire
Innocan Pharma Announces Offering of an Additional Debenture to Tamar Innovest
Innocan Pharma Announces Offering of an Additional Debenture to Tamar Innovest PR Newswire
31.03.26 - PR Newswire
Innocan Pharma Reports 2025 Financial Results, with Revenues at US $26.6M
Innocan Pharma Reports 2025 Financial Results, with Revenues at US $26.6M PR Newswire
31.03.26 - PR Newswire
Innocan Pharma Reports 2025 Financial Results, with Revenues at US $26.6M
Innocan Pharma Reports 2025 Financial Results, with Revenues at US $26.6M PR Newswire
16.03.26 - PR Newswire
Innocan Pharma Announces Closing of a Debenture to its Largest Shareholder, Tamar Innovest
Innocan Pharma Announces Closing of a Debenture to its Largest Shareholder, Tamar Innovest PR Newswire
11.03.26 - PR Newswire
Innocan Pharma Announces Offering of a Debenture to its Largest Shareholder, Tamar Innovest
Innocan Pharma Announces Offering of a Debenture to its Largest Shareholder, Tamar Innovest PR Newswire
27.02.26 - PR Newswire
FDA Center for Veterinary Medicine Grants Innocan a Fee Waiver in 2026 for the Third Consecutive Time
FDA Center for Veterinary Medicine Grants Innocan a Fee Waiver in 2026 for the Third Consecutive Time PR Newswire
09.02.26 - PR Newswire
Innocan Pharma Announces LPT-CBD demonstrates Pain Relief over Placebo-Results from a randomized blinded clinical study in Dogs
Innocan Pharma Announces LPT-CBD demonstrates Pain Relief over Placebo-​Results from a randomized blinded clinical study in Dogs PR Newswire
09.02.26 - PR Newswire
Innocan Pharma Announces LPT-CBD demonstrates Pain Relief over Placebo-Results from a randomized blinded clinical study in Dogs
Innocan Pharma Announces LPT-CBD demonstrates Pain Relief over Placebo-​Results from a randomized blinded clinical study in Dogs PR Newswire
27.01.26 - PR Newswire
Innocan Pharma Corporation Anticipates Listing on the NYSE American Stock Exchange with Concurrent Offering
Innocan Pharma Corporation Anticipates Listing on the NYSE American Stock Exchange with Concurrent Offering PR Newswire
27.01.26 - PR Newswire
Innocan Pharma Corporation Anticipates Listing on the NYSE American Stock Exchange with Concurrent Offering
Innocan Pharma Corporation Anticipates Listing on the NYSE American Stock Exchange with Concurrent Offering PR Newswire
02.01.26 - PR Newswire
Innocan Pharma Corporation Anticipates Listing on the NYSE American Stock Exchange with Concurrent Offering
Innocan Pharma Corporation Anticipates Listing on the NYSE American Stock Exchange with Concurrent Offering PR Newswire
02.01.26 - PR Newswire
Innocan Pharma Corporation Anticipates Listing on the NYSE American Stock Exchange with Concurrent Offering
Innocan Pharma Corporation Anticipates Listing on the NYSE American Stock Exchange with Concurrent Offering PR Newswire
10.12.25 - PR Newswire
Innocan Pharma Announces Public Filing of Amended Registration Statement for Proposed U.S. Public Offering
Innocan Pharma Announces Public Filing of Amended Registration Statement for Proposed U.S. Public Offering PR Newswire
27.11.25 - PR Newswire
Innocan Pharma Reports Financial Results for Q3 2025, with Revenues at US $21.6M
Innocan Pharma Reports Financial Results for Q3 2025, with Revenues at US $21.6M PR Newswire
24.11.25 - PR Newswire
Innocan Pharma Announces Promising Translational Evidence from a Pain Relief Study of Repeated LPT-CBD Administration in Goats
Innocan Pharma Announces Promising Translational Evidence from a Pain Relief Study of Repeated LPT-CBD Administration in Goats PR Newswire
20.11.25 - PR Newswire
Innocan Pharma announces promising results of LPT-CBD administered to Gottingen Minipigs, a well-known drug toxicology model
Innocan Pharma announces promising results of LPT-CBD administered to Gottingen Minipigs, a well-​known drug toxicology model PR Newswire
24.10.25 - PR Newswire
Innocan Pharma to Present at the 2025 ThinkEquity Conference
Innocan Pharma to Present at the 2025 ThinkEquity Conference PR Newswire
15.10.25 - PR Newswire
Liposomal CBD Injection Technology (LPT-CBD) patent was allowed in Japan
Liposomal CBD Injection Technology (LPT-CBD) patent was allowed in Japan PR Newswire
18.09.25 - PR Newswire
Innocan Pharma Partners With a Sanctuary For Injured Animals to Bring Remedy and Hope with its LPT-CBD injection
Innocan Pharma Partners With a Sanctuary For Injured Animals to Bring Remedy and Hope with its LPT-CBD injection PR Newswire

Newssuche

Videos

newspaper
16.04.26 +2,80%
Technical Trading: Treffsichere Signale für Gold
Gold Long Typ: Turbo Open End WKN: VC5S7W Hebel: 2 Laufzeit: OpenEnd Einstieg: Market ... Mehr »